Research and Markets: Peritoneal Cancer - Pipeline Review, H1 2015 - 59 Companies & 83 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/4smpr2/peritoneal_cancer) has announced the addition of the "Peritoneal Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peritoneal Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Peritoneal Cancer - Companies Involved in Therapeutics Development - 30 of the 59 Companies

  • AbbVie Inc.
  • Acceleron Pharma, Inc.
  • Adaptimmune Limited
  • Advanced Accelerator Applications SA
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Basilea Pharmaceutica AG
  • Bayer AG
  • BioMarin Pharmaceutical Inc.
  • Bionomics Limited
  • Boehringer Ingelheim GmbH
  • Celldex Therapeutics, Inc.
  • Celsion Corporation
  • Cerulean Pharma, Inc.
  • Clovis Oncology, Inc.
  • Corcept Therapeutics Incorporated
  • CritiTech, Inc.
  • CTI BioPharma Corp.
  • Eli Lilly and Company
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Galena Biopharma, Inc.
  • Genelux Corporation
  • Genentech, Inc.
  • GlaxoSmithKline plc
  • Glycotope GmbH
  • Hemispherx Biopharma, Inc.
  • ImmunoGen, Inc.

For more information visit http://www.researchandmarkets.com/research/4smpr2/peritoneal_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology